Triamcinolone Diacetate
Spezifikationen
67-78-7CAS-Nummer
200-669-0EG-Nummer
[2-[(8S,9R,10S,11S,13S,14S,16R,17S)-16-acetyloxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetateIUPAC-Name
C25H31FO8Chemische Formel
478.5 g/molMolekulargewicht
TRIAMCINOLONE DIACETATE; 67-78-7; Aristocort Forte; Tedarol; Triamcinolone 16,21-diacetate; DTXSID0048713; A73MM2Q32P; NSC-757356; DTXCID3028639; Pregna-1,4-diene-3,20-dione, 16,21-bis(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11beta,16alpha)-; RefChem:56156; Polcortolon; Orion; Aristocort diacetate; Kenacourt; Aristocort Parenterals; C25H31FO8; CHEBI:9669; Aristocort diacetate forte; Aristocort Forte Parenteral; 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,21-diacetate; NCGC00159320-03; (11beta,16alpha)-16,21-Bis(acetyloxy)-9-fluoro-11,17-dihydroxypregna-1,4-diene-3,20-dione; CAS-67-78-7; 2-((8S,9R,10S,11S,13S,14S,16R,17S)-16-Acetoxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate; Triamcinolone diacetate [JAN]; 357RP; EINECS 200-669-0; Triamcinolone 16-alpha,21-di(acetate); Triamcinolone EP Impurity A; UNII-A73MM2Q32P; 8357RP; MFCD00056462; XGMPVBXKDAHORN-RBWIMXSLSA-N; Triamcinolone diacetate [USP:JAN]; [2-[(8S,9R,10S,11S,13S,14S,16R,17S)-16-acetoxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate; 16alpha-Hydroxy-9alpha-fluoroprednisolone diacetate; 16alpha,21-Diacetoxy-9alpha-fluoro-11beta,17alpha-dihydroxy-1,4-pregnadiene-3,20-dione; 9-alpha-Fluoro-16-alpha-hydroxyprednisolone diacetate; delta1,9alpha-Fluoro-16alpha-hydroxyhydrocortisone diacetate; delta11,16alpha-Hydroxy-9alpha-fluorohydrocortisone diacetate; 9-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,21-diacetate; SCHEMBL12549; orb1705370; orb3140210; Aristocort Forte; Aristocort Forte Parenteral; Aristocort Parenterals; CHEMBL1200449; MSK2252; Triamcinolone diacetate (JAN/USP); Tox21_113119; BDBM50247986; MSK2252-100A; AKOS025402044; MSK2252-1000A; Tox21_113119_1; AC-3522; FT65195; NSC 757356; TRIAMCINOLONE DIACETATE [MART.]; TRIAMCINOLONE DIACETATE [VANDF]; TRIAMCINOLONE DIACETATE [USP-RS]; TRIAMCINOLONE DIACETATE [WHO-DD]; NCGC00159320-02; NCGC00159320-04; [2-[(8S,9R,10S,11S,13S,14S,16R,17S)-16-acetyloxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate; Pregna-1,4-diene-2,20-dione, 9-fluoro-11-beta,16-alpha,17,21-tetrahydroxy-, 16,21-diacetate; TRIAMCINOLONE 16,21-DIACETATE [MI]; TRIAMCINOLONE DIACETATE [ORANGE BOOK]; TRIAMCINOLONE IMPURITY A [EP IMPURITY]; C08184; D00984; T20852; TRIAMCINOLONE DIACETATE [USP MONOGRAPH]; Q27108462; Triamcinolone diacetate Solution in Acetonitrile, 1000ug/mL; Triamcinolone diacetate Solution in Acetonitrile, 100ug/mL; Triamcinolone diacetate, United States Pharmacopeia (USP) Reference Standard; (11|_,16|_)-16,21-Bis(acetyloxy)-9-fluoro-11,17-dihydroxypregna-1,4-diene-3,20-dione; 9-Fluoro-11,17-dihydroxy-3,20-dioxo-11beta,16alpha-pregna-1,4-diene-16,21-diyl diacetateSynonyme
